Both Relypsa Inc (NASDAQ:RLYP) and Intercept Pharmaceuticals Inc (NASDAQ:ICPT) received welcome news recently as a competing drug to Relypsa’s Veltassa encounters some difficulties …
Healthcare analysts provide insight on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) with differing opinions.
Analysts are bullish on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Celldex Therapeutics, Inc. (NASDAQ:CLDX) as Valeant’s CEO has returned from sick leave and …
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is making headlines with the sudden announcement of the CEO’s retirement and an application delay for the company’s leading drug.
